A Novel Nanocapsule Delivery System to Overcome Intestinal Degradation and Drug Transport Limited Absorption of P-glycoprotein Substrate Drugs

被引：0
|
作者：
Taher Nassar
Alona Rom
Abraham Nyska
Simon Benita
机构：
[1] The Hebrew University of Jerusalem,Department of Pharmaceutics, School of Pharmacy
[2] Tel Aviv University,Consultant in Toxicological Pathology, Sackler School of Medicine
来源：
Pharmaceutical Research | 2008年 / 25卷
关键词：
CYP3A; nanocapsules; P-gp; tacrolimus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2019 / 2029
页数：10
相关论文
共 50 条
  • [1] A Novel Nanocapsule Delivery System to Overcome Intestinal Degradation and Drug Transport Limited Absorption of P-glycoprotein Substrate Drugs
    Nassar, Taher
    Rom, Alona
    Nyska, Abraham
    Benita, Simon
    PHARMACEUTICAL RESEARCH, 2008, 25 (09) : 2019 - 2029
  • [2] Limited role of P-glycoprotein in the intestinal absorption of cyclosporin A
    Lee, YJ
    Chung, SJ
    Shim, CK
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (04) : 760 - 763
  • [3] Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
    Kono, Yusuke
    Kawahara, Iichiro
    Shinozaki, Kohei
    Nomura, Ikuo
    Marutani, Honoka
    Yamamoto, Akira
    Fujita, Takuya
    PHARMACEUTICS, 2021, 13 (03)
  • [4] Functional role of P-glycoprotein in limiting intestinal absorption of drugs: Contribution of passive permeability to P-glycoprotein mediated efflux transport
    Varma, Manthena V. S.
    Sateesh, Khandavilli
    Panchagnula, Ramesh
    MOLECULAR PHARMACEUTICS, 2005, 2 (01) : 12 - 21
  • [5] Intestinal absorption of pallidifloside D are limited by P-glycoprotein in mice
    Wang, Ming-Yu
    Yang, Ming
    Hou, Pi-Yong
    Chen, Xiu-Bo
    Li, Hong-Gang
    Yan, Jiu-Xing
    Zhang, Jun
    Zhang, Yan-Wen
    Wu, Xiao-Hui
    XENOBIOTICA, 2018, 48 (07) : 739 - 744
  • [6] The P-Glycoprotein Transport System and Cardiovascular Drugs
    Wessler, Jeffrey D.
    Grip, Laura T.
    Mendell, Jeanne
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (25) : 2495 - 2502
  • [7] Determinants of Intestinal Availability for P-glycoprotein Substrate Drugs Estimated by Extensive Simulation With Mathematical Absorption Models
    Ando, Hirotaka
    Hatakeyama, Hiroto
    Sato, Hiromi
    Hisaka, Akihiro
    Suzuki, Hiroshi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2771 - 2779
  • [8] Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs:: In vitro/in vivo case studies
    Constantinides, Panayiotis P.
    Wasan, Kishor M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (02) : 235 - 248
  • [9] Effects of β-cyclodextrin on the intestinal absorption of berberine hydrochloride, a P-glycoprotein substrate
    Zhang, Ye
    Cui, Yuan-Lu
    Gao, Li-Na
    Jiang, Heng-Li
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2013, 59 : 363 - 371
  • [10] Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol
    Spahn-Langguth, H
    Langguth, P
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 12 (04) : 361 - 367
12345